Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OSTIVA
- Development stage
- Unknown
- Lead developer
- Sciele Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
OSTIVA is a prescription-strength oral nutritional supplement developed by Sciele Pharma (now part of Shionogi) specifically formulated to support bone health in women. The product contains a combination of essential minerals, including calcium and magnesium, alongside vitamins D, B6, B12, and Metafolin (L-methylfolate). OSTIVA is designed to address bone health through two primary pathways: providing the necessary building blocks for bone mineralization and reducing elevated homocysteine levels, which are associated with increased fracture risk and bone fragility. By utilizing Metafolin, the bioactive form of folate, the formulation ensures efficient homocysteine metabolism even in individuals with genetic polymorphisms in the MTHFR enzyme. It is marketed as a prescription product to ensure medical oversight in managing nutritional deficiencies related to skeletal maintenance.
- Brand names
- OSTIVA
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on OSTIVA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OSTIVA.